This is a short survey of 10 questions regarding screening for distress. Screening means the application of a tool, test or judgement in order to identify a group of patients who would (presumably) otherwise be overlooked. The details of how, when and which tool will vary. Distress means significant emotional upset associated with cancer to the extent that a clinical intervention may be required. This is an area of much debate, therefore your opinion, positive or negative counts to assess general current consensus.

I appreciate you taking the time to answer the following questions based on your current opinion.

* 1. How are clinicians mainly screening for distress in cancer in your organization?

* 2. How and when is screening for distress in cancer presented to patients in your organization?

* 3. In your opinion, is the process of screening for distress perceived as a burden in your organization (regardless of its effectiveness)?

* 4. In your opinion, does screening for distress benefit patients in your organization (regardless of burden)?

* 5. In general, should screening for distress be expanded to improve coverage for any of the following groups?

* 6. What do you think should be included when screening for distress (ie in addition to distress)?

* 7. Are you convinced by the evidence regarding possible benefits of screening for distress in cancer?

* 8. How do you think screening for distress in cancer can be improved in the future?

* 9. What do you think should be the role of national or international organizations regarding screening?

* 10. Finally, what do you think of the prospect of novel self-assessment screening over the internet? (eg patients answer questions over the internet at home, receive a score which is sent or brought to a clinical appointment)